Clinical trial
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate…
NCT00024167 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00024167 |
|---|---|
| Title | Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer |
| Official title | A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Docetaxel, Doxorubicin hydrochloride, Estramustine phosphate sodium, Ketoconazole, Prednisone, Vinblastine, Strontium chloride Sr 89, Dexamethasone |
| Enrollment | 265 |
| Start date | Apr 1, 2002 |
| Primary completion | Sep 1, 2014 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 22, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: